Glucotrack, Inc. Net Income Loss

• Glucotrack, Inc. showed an increase of +14.2% in Net Income Loss from 2024 to 2025.
• This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2005 to 2025 (21 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2012: -$635.0 thousand | Q2 2012: -$737.5 thousand | Q3 2012: -$700.6 thousand | Q1 2013: -$1.34 million | Q2 2013: -$576.6 thousand | Q3 2013: -$699.9 thousand | Q1 2014: -$736.9 thousand | Q2 2014: $5.26 million | Q3 2014: -$769.6 thousand | Q1 2015: -$1.53 million | Q2 2015: -$1.67 million | Q3 2015: -$1.10 million | Q1 2016: -$1.23 million | Q2 2016: -$1.59 million | Q3 2016: -$1.45 million | Q1 2017: -$2.53 million | Q2 2017: -$2.56 million | Q3 2017: -$2.58 million | Q1 2018: $1.85 million | Q2 2018: -$1.96 million | Q3 2018: -$1.57 million | Q1 2019: -$1.02 million | Q2 2019: -$898.9 thousand | Q3 2019: -$996.8 thousand | Q1 2020: -$734.0 thousand | Q2 2020: -$574.0 thousand | Q3 2020: -$509.0 thousand | Q1 2021: -$904.0 thousand | Q2 2021: -$853.0 thousand | Q3 2021: -$804.0 thousand | Q1 2022: -$1.09 million | Q2 2022: -$1.13 million | Q3 2022: -$928.0 thousand | Q1 2023: -$1.29 million | Q2 2023: -$1.18 million | Q3 2023: -$2.22 million | Q1 2024: -$2.93 million | Q2 2024: -$4.49 million | Q3 2024: -$5.09 million | Q1 2025: -$6.83 million | Q2 2025: -$4.76 million | Q3 2025: -$4.17 million.
• Over the full 21 years of available data (2005 to 2025), Glucotrack, Inc.'s Net Income Loss has declined by 1,736.7%.
• Historical annual values: Fiscal year 2025: -$19.39 million | Fiscal year 2024: -$22.60 million | Fiscal year 2023: -$7.10 million | Fiscal year 2022: -$4.44 million | Fiscal year 2021: -$4.07 million | Fiscal year 2020: -$2.70 million | Fiscal year 2019: $3.52 million | Fiscal year 2018: -$6.72 million | Fiscal year 2017: $10.33 million | Fiscal year 2016: -$5.41 million | Fiscal year 2015: -$5.84 million | Fiscal year 2014: $2.98 million | Fiscal year 2013: -$9.80 million | Fiscal year 2012: -$2.77 million | Fiscal year 2011: -$2.36 million | Fiscal year 2010: -$2.79 million | Fiscal year 2009: -$1.20 million | Fiscal year 2008: -$1.53 million | Fiscal year 2007: -$1.59 million | Fiscal year 2006: -$1.28 million | Fiscal year 2005: -$1.06 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026